Advertisement
Letter to the Editor| Volume 54, ISSUE 1, P45-47, April 2009

Increased CCL1 levels in the sera and blister fluid of patients with bullous pemphigoid

      Bullous pemphigoid (BP) is an autoimmune blistering skin disease characterized by large, tense blisters. Production of autoantibodies against the 180-kDa hemidesmosomal protein of the basement membrane zone is regarded as the first event of the pathomechanism [
      • Labib R.S.
      • Anhalt G.J.
      • Patel H.P.
      • Mutasim D.F.
      • Diaz L.A.
      Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.
      ]. Once the autoantibodies bind to the basement membrane, a cascade of inflammatory events occurs, resulting in subsequent blister formation at the dermoepidermal junction. During this process, cytokines and chemokines are considered to play crucial roles in inflammatory cell recruitment, deposition and perpetuation [
      • Pastore S.
      • Mascia F.
      • Mariotti F.
      • Dattilo C.
      • Girolomoni G.
      Chemokine networks in inflammatory skin diseases.
      ]. Therefore, clarifying the serum and local levels of cytokines and chemokines may help in understanding the immune dysregulation in the pathomechanism of BP.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Labib R.S.
        • Anhalt G.J.
        • Patel H.P.
        • Mutasim D.F.
        • Diaz L.A.
        Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.
        J Immunol. 1986; 136: 1231-1235
        • Pastore S.
        • Mascia F.
        • Mariotti F.
        • Dattilo C.
        • Girolomoni G.
        Chemokine networks in inflammatory skin diseases.
        Eur J Dermatol. 1994; 130: 128-129
        • Goya I.
        • Gutierrez J.
        • Varona R.
        • Kremer L.
        • Zaballos A.
        • Marquez G.
        Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3.
        J Immunol. 1998; 160: 1975-1981
        • Zingoni A.
        • Soto H.
        • Hedrick J.A.
        • Stoppacciaro A.
        • Storlazzi C.T.
        • Sinigaglia F.
        • et al.
        The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells.
        J Immunol. 1998; 161: 547-551
        • Sebastiani S.
        • Allavena P.
        • Albanesi C.
        • Nasorri F.
        • Bianchi G.
        • Traidl C.
        • et al.
        Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.
        J Immunol. 2001; 166: 996-1002
        • Montes-Visuet R.
        • Vega-Miranda A.
        • Valencia-Maqueda E.
        • Negrete-Garcia M.C.
        • Velasquez J.R.
        • Teran L.M.
        CC chemokine ligand 1 is released into the airways of atopic asthmatics.
        Eur Respir J. 2006; 28: 59-67
        • Gombert M.
        • Dieu-Nosjean M.C.
        • Winterberg F.
        • Bunemann E.
        • Kubitza R.C.
        • Da Cunha L.
        • et al.
        CCL1–CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.
        J Immunol. 2005; 174: 5082-5091
        • Haque N.S.
        • Zhang X.
        • French D.L.
        • Li J.
        • Poon M.
        • Fallon J.T.
        • et al.
        CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells.
        Circulation. 2000; 102: 786-792
        • Dvorak A.M.
        • Mihm Jr., M.C.
        • Osage J.E.
        • Kwan T.H.
        • Austen K.F.
        • Wintroub B.U.
        Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient.
        J Invest Dermatol. 1982; 78: 91-101
        • Dopp R.
        • Schmidt E.
        • Chimanovitch I.
        • Leverkus M.
        • Brocker E.B.
        • Zillikens D.
        IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
        J Am Acad Dermatol. 2000; 42: 577-583